Table 1
Increased serum FGF21 levels in metabolic disease patients with insulin resistance.
Disease | Insulin signaling | Serum FGF21 levels |
---|---|---|
Nonalcoholic fatty liver disease | Resistance | Increase |
Type 2 diabetes | Resistance | Increase |
Obesity | Resistance | Increase |
Cushing's syndrome | Resistance | Increase |
Lipodystrophy induced by HIV-1 | Resistance | Increase |
Endostage renal disease | Resistance | Increase |